News about "Saul Faust"

UK Health Security Agency Supports Development of Fridge-Free Tetanus-Diphtheria Vaccine SPVX02 After Successful Phase I Trial

UK Health Security Agency Supports Development of Fridge-Free Tetanus-Diphtheria Vaccine SPVX02 After Successful Phase I Trial

UK Health Security Agency and Stablepharma report positive Phase I results for SPVX02, a fridge-free Tetanus and Diphtheria vaccine stable at 30°C for 24 months.

Saul Faust | 17/03/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members